Pia Nierman

904 total citations
12 papers, 394 citations indexed

About

Pia Nierman is a scholar working on Genetics, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Pia Nierman has authored 12 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 7 papers in Immunology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Pia Nierman's work include Chronic Lymphocytic Leukemia Research (12 papers), Lymphoma Diagnosis and Treatment (6 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). Pia Nierman is often cited by papers focused on Chronic Lymphocytic Leukemia Research (12 papers), Lymphoma Diagnosis and Treatment (6 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). Pia Nierman collaborates with scholars based in United States, India and Germany. Pia Nierman's co-authors include Adrian Wiestner, Susan Soto, Inhye E. Ahn, Jennifer Lotter, Xin Tian, Janet Valdez, Sarah E. M. Herman, Chingiz Underbayev, Clare Sun and Laura Wake and has published in prestigious journals such as Blood, Clinical Cancer Research and Academic Radiology.

In The Last Decade

Pia Nierman

10 papers receiving 387 citations

Peers

Pia Nierman
Yuh Shan Lee Singapore
Abraham Varghese United Kingdom
Claes Karlsson Sweden
K. R. United States
Viktoria Hjalmar Sweden
Petra Langerbeins Germany
Noboru Yonetani Japan
Monica Tozzi Italy
Lori A. Leslie United States
Amy Goodrich United States
Yuh Shan Lee Singapore
Pia Nierman
Citations per year, relative to Pia Nierman Pia Nierman (= 1×) peers Yuh Shan Lee

Countries citing papers authored by Pia Nierman

Since Specialization
Citations

This map shows the geographic impact of Pia Nierman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pia Nierman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pia Nierman more than expected).

Fields of papers citing papers by Pia Nierman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pia Nierman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pia Nierman. The network helps show where Pia Nierman may publish in the future.

Co-authorship network of co-authors of Pia Nierman

This figure shows the co-authorship network connecting the top 25 collaborators of Pia Nierman. A scholar is included among the top collaborators of Pia Nierman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pia Nierman. Pia Nierman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Brofferio, Alessandra, Jeanine Superata, Susan Soto, et al.. (2024). Cardiac Monitoring of Patients on Btki for Chronic Lymphocytic Leukemia. Blood. 144(Supplement 1). 6787–6787.
3.
Chen, Jonathan, Erika M. Gaglione, Chingiz Underbayev, et al.. (2023). CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy. Clinical Cancer Research. 29(18). 3612–3621. 11 indexed citations
4.
Hsu, Li‐Yueh, Clare Sun, Pia Nierman, et al.. (2022). Splenic Size and Volume Measurements in Patients with Chronic Lymphocytic Leukemia. Academic Radiology. 30(6). 1056–1065. 1 indexed citations
5.
Pleyer, Christopher, Kerry J. Laing, Mir A. Ali, et al.. (2022). BTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLL. Blood Advances. 6(6). 1732–1740. 18 indexed citations
6.
Cheung, Jean, Michael Gulrajani, Erika M. Gaglione, et al.. (2020). Pharmacodynamic Analysis of BTK Inhibition in Patients with Chronic Lymphocytic Leukemia Treated with Acalabrutinib. Clinical Cancer Research. 26(12). 2800–2809. 21 indexed citations
7.
Pleyer, Christopher, Clare Sun, Inhye E. Ahn, et al.. (2020). Reconstitution of humoral immunity and decreased risk of infections in patients with chronic lymphocytic leukemia treated with Bruton tyrosine kinase inhibitors. Leukemia & lymphoma. 61(10). 2375–2382. 15 indexed citations
8.
Pleyer, Christopher, Mir A. Ali, Jeffrey I. Cohen, et al.. (2020). Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines. Blood. 137(2). 185–189. 84 indexed citations
9.
10.
Ahn, Inhye E., Chingiz Underbayev, Erika M. Gaglione, et al.. (2019). Diverging Clonal Evolution during Sequential Therapy with Chemoimmunotherapy Followed By BTK Inhibitors. Blood. 134(Supplement_1). 850–850. 1 indexed citations
11.
Sun, Clare, Pia Nierman, Inhye E. Ahn, et al.. (2018). Acalabrutinib in Patients with Relapsed/Refractory (R/R) and High-Risk, Treatment-Naive (TN) Chronic Lymphocytic Leukemia (CLL). Blood. 132(Supplement 1). 4424–4424. 7 indexed citations
12.
Ahn, Inhye E., Chingiz Underbayev, Adam Albitar, et al.. (2017). Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia. Blood. 129(11). 1469–1479. 229 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuh Shan Lee Breakdown of academic impact, for papers by Abraham Varghese Breakdown of academic impact, for papers by Claes Karlsson Breakdown of academic impact, for papers by K. R. Breakdown of academic impact, for papers by Viktoria Hjalmar Breakdown of academic impact, for papers by Petra Langerbeins Breakdown of academic impact, for papers by Noboru Yonetani Breakdown of academic impact, for papers by Monica Tozzi Breakdown of academic impact, for papers by Lori A. Leslie Breakdown of academic impact, for papers by Amy Goodrich
Rankless by CCL
2026